TAGI Pharma, Inc.

Manufacturer / marketing-authorisation holder

TAGI Pharma, Inc. — 15 products across 1 markets, 1 brand names. Products are grouped by country; brand names link to their brand page and ingredients to the ingredient or combination page. It is the marketing-authorisation holder recorded by the regulator, not necessarily the factory.

TAGI Pharma, Inc. — 15 productos en 1 mercados, 1 nombres comerciales. Los productos se agrupan por país; los nombres comerciales enlazan a su página de marca y los principios activos a la página del principio o de la combinación. Es el titular registrado por el regulador, no necesariamente la fábrica.

TAGI Pharma, Inc. —— 共 15 个产品,覆盖 1 个市场、1 个品牌名。产品按国家分组;品牌名链到品牌页,成分链到成分页/组合页。这里记录的是监管数据里的「上市许可持有人」,不一定是生产工厂。

15 products · 1 markets · 1 brand names

15 productos · 1 mercados · 1 marcas

15 个产品 · 1 个市场 · 1 个品牌名

Products by country

US (15 records)

Source: api.fda.gov

BrandActive ingredient(s)Form
CHOLESTYRAMINE LIGHTCholestyraminepowder
—Benzonatatecapsule
—盐酸二甲双胍tablet
—盐酸纳曲酮tablet
—加巴喷丁tablet
—阿奇霉素tablet
—Chlorthalidonetablet
—Cholestyraminepowder
—左乙拉西坦injection
—阿奇霉素tablet
—Chlorthalidonetablet
—盐酸二甲双胍tablet
—Phenterminetablet
—Benzonatatecapsule
—加巴喷丁tablet
Source & licence: product rows link to the regulator record (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA); facts only — see the licence register.